European Union officials have accused Mastercard of overcharging consumers with the fees the company charges. “We currently suspect Mastercard is artificially raising the costs of card payments,” said the EU statement.
Those fees harm consumers and retailers in the EU, competition commissioner Margrethe Vestager said. The credit card company said it was “working with the European Commission on the issue” and was preparing a formal response.
“Throughout this procedure we have kept the needs of both consumers and merchants in mind,” Mastercard said.
The EU is focusing on what is known as ‘interchange fees’ – the fees retailers pay banks to process card payments.
Officials say they are concerned that Mastercard violates competition rules by requiring retailers to pay artificially inflated fees to process credit card transactions.
They say this practice leads to higher prices for retailers in the EU, which they then pass on to consumers. The charges from the EU are part of a long-running investigation.
The maximum fine that the EU can impose for antitrust infringements is 10% of the company’s annual sales, according to the EU.
A separate investigation into Visa’s interchange fees is also being carried out by the EU.
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas